S. 316 - Preserve Access to Affordable Generics Act
- Sponsor:
- Herbert Kohl
- Summary:
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Status:
- The bill has passed through committee and has been put on a legislative calendar.
Preserve Access to Affordable Generics Act
S. 316 — 110th Congress (2007–2008)
- Summary
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
- Other Titles
- Preserve Access to Affordable Generics Act
- Preserve Access to Affordable Generics Act
- Sponsor
- Herbert Kohl
- Co-Sponsors
- Subjects
- Business
- Antitrust law
- Competition
- Congress
- Congressional reporting requirements
- Criminal investigation
- Criminal justice
- Drug industry
- Generic drugs
- Governmental investigations
- Intellectual property
- Marketing
- Medical care
- Medicine
- Patent infringement
- Pharmaceutical research
- Restrictive trade practices
- Science policy
- Related Bills
- Major Actions
Introduced 1/17/2007 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 1/17/2007 1/17/2007 Read twice and referred to the Committee on the Judiciary. 1/17/2007 Committee on the Judiciary. Hearings held. 1/17/2007 Sponsor introductory remarks on measure. (CR S679) 2/15/2007 Committee on the Judiciary. Approved for reporting without amendment favorably. 2/27/2007 Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report. Put on a legislative calendar 2/27/2007 Placed on Senate Legislative Calendar under General Orders. Calendar No. 59. 3/07/2007 Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held. Number Sponsor Date Offered Status
- chart
- table
Total contributions given to Senators from Pharmaceutical manufacturing, which…
opposed this bill
| Pharmaceutical manufacturing | $6,312,735 |
| $6,312,735 |
Contributions data source: OpenSecrets.org
